Literature DB >> 6249617

Antagonism of an indirectly acting agonist: block by propranolol and sotalol of the action of tyramine on rat heart.

J W Black, D H Jenkinson, T P Kenakin.   

Abstract

Some agonists act indirectly in the sense that they cause the release of a second substance that brings about the response finally observed. An antagonist which competitively inhibits the action of the intermediate substance will also reduce the response to the indirectly acting agonist, provided that the receptors are freely accessible. A simple mass-law model for indirect antagonism of this kind is presented, and its predictions are compared with the results obtained in an experimental study of the influence of propranolol and sotalol on the inotropic response of isolated rat atria to tyramine. While there is reasonable qualitative agreement, the fit is not exact and reasons for this are discussed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6249617     DOI: 10.1016/0014-2999(80)90202-2

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  10 in total

1.  Nobel lecture in physiology or medicine--1988. Drugs from emasculated hormones: the principle of syntopic antagonism.

Authors:  J Black
Journal:  In Vitro Cell Dev Biol       Date:  1989-04

2.  Quantification of H2-agonism by clonidine and dimaprit in an adenylate cyclase assay.

Authors:  D G Trist; P Leff
Journal:  Agents Actions       Date:  1985-04

3.  The half-life of endothelium-derived relaxing factor released from bovine aortic endothelial cells in culture.

Authors:  J A Angus; T M Cocks
Journal:  J Physiol       Date:  1987-07       Impact factor: 5.182

4.  The endogenous cannabinoid agonist, anandamide stimulates sensory nerves in guinea-pig airways.

Authors:  R C Tucker; M Kagaya; C P Page; D Spina
Journal:  Br J Pharmacol       Date:  2001-03       Impact factor: 8.739

5.  Inhibition of endothelium-dependent vasorelaxation by arginine analogues: a pharmacological analysis of agonist and tissue dependence.

Authors:  G R Martin; M L Bolofo; H Giles
Journal:  Br J Pharmacol       Date:  1992-03       Impact factor: 8.739

6.  CC12, a high-affinity ligand for [3H]cimetidine binding, is an improgan antagonist.

Authors:  Lindsay B Hough; Julia W Nalwalk; James G Phillips; Brian Kern; Zhixing Shan; Mark P Wentland; Iwan J P de Esch; Elwin Janssen; Travis Barr; Rebecca Stadel
Journal:  Neuropharmacology       Date:  2007-01-20       Impact factor: 5.250

7.  Pharmacological analysis of the pentagastrin-tiotidine interaction in the mouse isolated stomach.

Authors:  J W Black; P Leff; N P Shankley
Journal:  Br J Pharmacol       Date:  1985-11       Impact factor: 8.739

8.  Lack of involvement of alpha-adrenoceptors in sympathetic neural vasoconstriction in the hindquarters of the rabbit.

Authors:  G D Hirst; M J Lew
Journal:  Br J Pharmacol       Date:  1987-01       Impact factor: 8.739

9.  Pharmacologic analysis of LY188695 (KB-2413), 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)-benzimidazole difumarate, a potent histamine1 receptor antagonist.

Authors:  J H Fleisch; L E Rinkema; K D Haisch; C A Whitesitt
Journal:  Agents Actions       Date:  1987-02

10.  Beta-blockade antagonism of tyramine-induced rise in blood pressure.

Authors:  F Colombo; R Sega; F Mailland; R Rigo; L Palvarini; A Libretti
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.